The current prognostic models for patients with advanced urinary tract cancers were developed and validated in the chemotherapy setting. As immunotherapy has become the backbone of novel treatments, updated prognostic scores are needed.

A novel immunotherapy prognostic score for patients with pretreated advanced urInary TrAct CArcinoma from the subgroup analysis of the SAUL study: the ITACA Score / Fornarini, Giuseppe; Rebuzzi, Sara E; Buti, Sebastiano; Rescigno, Pasquale; Merseburger, Axel; Sternberg, Cora N; de Giorgi, Ugo; Basso, Umberto; Maruzzo, Marco; Giannatempo, Patrizia; Ponzano, Marta; Giunta, Emilio F; Catalano, Fabio; Murianni, Veronica; Damassi, Alessandra; Cremante, Malvina; Gandini, Annalice; Puglisi, Silvia; Llaja Obispo, Miguel A; Signori, Alessio; Banna, Giuseppe L. - In: MINERVA UROLOGY AND NEPHROLOGY. - ISSN 2724-6442. - (2022). [10.23736/S2724-6051.22.05135-7]

A novel immunotherapy prognostic score for patients with pretreated advanced urInary TrAct CArcinoma from the subgroup analysis of the SAUL study: the ITACA Score

Buti, Sebastiano;
2022-01-01

Abstract

The current prognostic models for patients with advanced urinary tract cancers were developed and validated in the chemotherapy setting. As immunotherapy has become the backbone of novel treatments, updated prognostic scores are needed.
2022
A novel immunotherapy prognostic score for patients with pretreated advanced urInary TrAct CArcinoma from the subgroup analysis of the SAUL study: the ITACA Score / Fornarini, Giuseppe; Rebuzzi, Sara E; Buti, Sebastiano; Rescigno, Pasquale; Merseburger, Axel; Sternberg, Cora N; de Giorgi, Ugo; Basso, Umberto; Maruzzo, Marco; Giannatempo, Patrizia; Ponzano, Marta; Giunta, Emilio F; Catalano, Fabio; Murianni, Veronica; Damassi, Alessandra; Cremante, Malvina; Gandini, Annalice; Puglisi, Silvia; Llaja Obispo, Miguel A; Signori, Alessio; Banna, Giuseppe L. - In: MINERVA UROLOGY AND NEPHROLOGY. - ISSN 2724-6442. - (2022). [10.23736/S2724-6051.22.05135-7]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2935671
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 3
social impact